Position in EVMN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$33,129,325
+$8,458,858 QoQ
Shares Held
1,441,032
0.0% QoQ
Ownership
4.00%
of shares outstanding
% of Portfolio
27.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EVMN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nan Fung Group Holdings Ltd holds $116,694,731 across 20 Biotechnology names. EVMN ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EVMN |
Evommune, Inc.
This page
|
1,441,032 | $33,129,325 | |
| 2 | MPLT |
MapLight Therapeutics, Inc.
|
971,253 | $19,745,573 | |
| 3 | LBRX |
Lb Pharmaceuticals Inc
|
630,657 | $15,552,001 | |
| 4 | OCS |
Oculis Holding AG
|
350,745 | $9,326,309 | |
| 5 | INCY |
Incyte Corp
|
53,742 | $5,058,197 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
15,722 | $4,668,962 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
49,120 | $4,271,966 | |
| 8 | CELC |
Celcuity Inc.
|
28,300 | $3,230,162 |
All Filings in EVMN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,129,325 | 1,441,032 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $24,670,467 | 1,441,032 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||